Should you buy Tempus AI stock now?
Yes, the technical signal for Tempus AI is currently Strong Buy. Tempus AI trades at $71.98 as of Oct 7, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 4.252 with falling momentum (signal: 5.130); RSI is at 48.7 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $68.56 is 4.8% below the current price. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Tempus AI stock?
The average analyst price target for Tempus AI is $68.56. The current price is $71.98, which gives a downside of 4.8%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $61.70 and $75.42.
Is Tempus AI a dividend stock?
No, Tempus AI does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Tempus AI stock?
Tempus AI is rated as a stock in the risk category Extremely speculative. the annual standard deviation is 73.3%, which classifies the stock as Extremely speculative.
Is Tempus AI overvalued?
Tempus AI is considered fairly valued – the price is close to the analyst price target. Tempus AI has the following valuation ratios: a P/S ratio of 9.6, a P/B ratio of 31.3. The stock trades close to the analyst price target and is considered fairly valued.
Is Tempus AI overbought?
No, Tempus AI is not overbought. RSI is at 48.7 (neutral zone). The technical indicators show: RSI is at 48.7 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 3.7% below the 20-day average (short-term downtrend). In addition, MACD is positive, but momentum is falling.
When is the next Tempus AI earnings report?
Tempus AI reports its next earnings on November 3, 2026. The stock currently trades at $71.98.
Is Tempus AI shorted?
Yes, Tempus AI is shorted with 27.8% of the free float sold short. This is an extremely high level of short selling, which points to great skepticism among institutional investors. The risk of a short squeeze on positive news or earnings is very high. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Tempus AI stock?
No, insiders are not buying Tempus AI shares – they are net sellers. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 69,164,425 $ sold. Active sellers include Eric P Lefkofsky, Andrew Polovin, Ryan M Bartolucci and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Tempus AI a good stock?
Based on our total score, Tempus AI is rated as a poor stock with a total score of 29 out of 100. The stock scores below average on value, quality and momentum – it sits at the lower end of the market. The score is made up of Value: 5/100, Quality: 15/100, Momentum: 68/100. In addition: technical signal: Strong Buy. Whether Tempus AI is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Tempus AI stock?
The outlook for Tempus AI based on current data: the average analyst price target is $68.56 (-4.8%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on Nov 3, 2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Tempus AI stock falling?
Tempus AI is falling right now. The technical indicators show: the price is 3.7% below the 20-day average; short interest is 27.8% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Tempus AI go?
The average analyst price target for Tempus AI is $68.56, which is 4.8% below the current price of $71.98. The stock has traded between $40.77 and $104.32 over the last 52 weeks. The price is 31.0% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Tempus AI fall?
The stock has traded as low as $40.77 over the last 52 weeks — that is 43.4% below the current price of $71.98. The biggest decline (drawdown) in the same period was 60.9% from high to low. Within a year, the price typically swings about ±73.3% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Tempus AI do?
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical com... The company belongs to the Healthcare sector, more specifically the Health Information Services industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Tempus AI as an investment.
Did Tempus AI raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Tempus AI. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Tempus AI making money or losing money?
No, Tempus AI is currently not making money — the company is losing money with a negative profit margin of -17.8%, a noticeable loss. That means the business loses money on every dollar of revenue. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Tempus AI go bankrupt?
The bankruptcy risk of Tempus AI is rated as elevated. Altman Z2 (a model for assessing financial distress) is -1.29 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 3 — which is weak. Debt relative to equity is 1,544% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Tempus AI have a lot of debt?
Yes, Tempus AI has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 1,544%. For the healthcare sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
